J. Jose Corbalan

970 total citations
15 papers, 671 citations indexed

About

J. Jose Corbalan is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, J. Jose Corbalan has authored 15 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Physiology. Recurrent topics in J. Jose Corbalan's work include Nitric Oxide and Endothelin Effects (4 papers), Blood Pressure and Hypertension Studies (3 papers) and Hormonal Regulation and Hypertension (3 papers). J. Jose Corbalan is often cited by papers focused on Nitric Oxide and Endothelin Effects (4 papers), Blood Pressure and Hypertension Studies (3 papers) and Hormonal Regulation and Hypertension (3 papers). J. Jose Corbalan collaborates with scholars based in United States, Ireland and Poland. J. Jose Corbalan's co-authors include Marek W. Radomski, Carlos Medina, Robert F. Jacob, Tadeusz Maliñski, Ronald P. Mason, Carlos Medina, Joanna McCarthy, Iwona Inkielewicz‐Stępniak, Stephen F. Vatner and Dorothy E. Vatner and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Lipid Research and Carcinogenesis.

In The Last Decade

J. Jose Corbalan

14 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Jose Corbalan United States 11 173 172 112 103 97 15 671
Xiaolei Hu China 14 170 1.0× 129 0.8× 71 0.6× 67 0.7× 88 0.9× 58 853
Yanjie Yang China 22 311 1.8× 242 1.4× 100 0.9× 150 1.5× 83 0.9× 84 1.4k
Huanhuan Liu China 18 179 1.0× 64 0.4× 73 0.7× 67 0.7× 44 0.5× 72 881
Omar Lozano Mexico 19 194 1.1× 362 2.1× 143 1.3× 157 1.5× 123 1.3× 52 976
Guoliang Jia China 17 218 1.3× 77 0.4× 59 0.5× 117 1.1× 81 0.8× 34 1.0k
Xiaoyan Wang China 21 595 3.4× 174 1.0× 118 1.1× 167 1.6× 82 0.8× 57 1.5k
Zuhong Tian China 12 373 2.2× 61 0.4× 92 0.8× 101 1.0× 61 0.6× 20 715
Elena C. Castillo Mexico 20 242 1.4× 88 0.5× 202 1.8× 65 0.6× 262 2.7× 35 1.0k
Ming Luo China 16 164 0.9× 292 1.7× 83 0.7× 100 1.0× 41 0.4× 74 1.2k

Countries citing papers authored by J. Jose Corbalan

Since Specialization
Citations

This map shows the geographic impact of J. Jose Corbalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jose Corbalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jose Corbalan more than expected).

Fields of papers citing papers by J. Jose Corbalan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jose Corbalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jose Corbalan. The network helps show where J. Jose Corbalan may publish in the future.

Co-authorship network of co-authors of J. Jose Corbalan

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jose Corbalan. A scholar is included among the top collaborators of J. Jose Corbalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jose Corbalan. J. Jose Corbalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Corbalan, J. Jose, et al.. (2024). Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis. Journal of Lipid Research. 65(12). 100695–100695.
2.
Corbalan, J. Jose, Dorothy E. Vatner, & Stephen F. Vatner. (2016). Myocardial apoptosis in heart disease: does the emperor have clothes?. Basic Research in Cardiology. 111(3). 31–31. 76 indexed citations
3.
Mason, R. Preston, Robert F. Jacob, J. Jose Corbalan, & Tadeusz Maliñski. (2015). EICOSAPENTAENOIC ACID REDUCES SMALL DENSE LOW DENSITY LIPOPROTEIN OXIDATION AND IMPROVES ENDOTHELIAL FUNCTION IN VITRO AS COMPARED TO OTHER TRIGLYCERIDE-LOWERING AGENTS. Journal of the American College of Cardiology. 65(10). A2139–A2139. 1 indexed citations
4.
Mason, Ronald P., et al.. (2015). Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.. PubMed. 66(1). 65–72. 24 indexed citations
5.
Mason, R. Preston, Robert F. Jacob, J. Jose Corbalan, & Tadeusz Maliñski. (2014). Combination Eicosapentaenoic Acid and Statin Treatment Reversed Endothelial Dysfunction in HUVECs Exposed to Oxidized LDL. Journal of clinical lipidology. 8(3). 342–343. 9 indexed citations
6.
Radziwon‐Balicka, Aneta, Maria José Santos-Martínez, J. Jose Corbalan, et al.. (2013). Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway. Carcinogenesis. 35(2). 324–332. 85 indexed citations
7.
Mason, Ronald P., Robert F. Jacob, J. Jose Corbalan, Roman Kaliszan, & Tadeusz Maliñski. (2013). Amlodipine Increased Endothelial Nitric Oxide and Decreased Nitroxidative Stress Disproportionately to Blood Pressure Changes. American Journal of Hypertension. 27(3). 482–488. 21 indexed citations
8.
Mason, Ronald P., et al.. (2013). The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells. BMC Pharmacology and Toxicology. 14(1). 48–48. 21 indexed citations
9.
Santos-Martínez, Maria José, Kamil Rahme, J. Jose Corbalan, et al.. (2013). Pegylation Increases Platelet Biocompatibility of Gold Nanoparticles. Journal of Biomedical Nanotechnology. 10(6). 1004–1015. 52 indexed citations
10.
Mason, Ronald P., Robert F. Jacob, J. Jose Corbalan, et al.. (2012). EFFECTS OF DIPEPTIDYL PEPTIDASE-4 INHIBITION ON ENDOTHELIAL NITRIC OXIDE RELEASE, BLOOD PRESSURE AND SICAM-1 LEVELS IN HYPERTENSIVE RATS. Journal of the American College of Cardiology. 59(13). E1543–E1543. 3 indexed citations
11.
Medina, Carlos, et al.. (2012). Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis. International Journal of Nanomedicine. 7. 631–631. 79 indexed citations
12.
McCarthy, Joanna, Iwona Inkielewicz‐Stępniak, J. Jose Corbalan, & Marek W. Radomski. (2012). Mechanisms of Toxicity of Amorphous Silica Nanoparticles on Human Lung Submucosal Cells in Vitro: Protective Effects of Fisetin. Chemical Research in Toxicology. 25(10). 2227–2235. 103 indexed citations
13.
Mason, Ronald P., Robert F. Jacob, Ruslan Kubant, et al.. (2012). Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants. British Journal of Clinical Pharmacology. 74(1). 141–146. 34 indexed citations
14.
Mason, Ronald P., Robert F. Jacob, Ruslan Kubant, et al.. (2012). Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Enhanced Nitric Oxide Release and Reduced Blood Pressure and sICAM-1 Levels in Hypertensive Rats. Journal of Cardiovascular Pharmacology. 60(5). 467–473. 67 indexed citations
15.
Medina, Carlos, et al.. (2011). Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects. International Journal of Nanomedicine. 6. 2821–2821. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026